These studies of partial pancreatectomy assess pancreatic proinsulin messenger RNA (mRNA) levels as an index of in vivo insulin biosynthesis, and show relationships to glucose homeostasis. Rats were subjected to sham operation, 50% pancreatectomy (Px), or 90% Px, and were examined after 1, 3, or 14 wk. Proinsulin mRNA was measured by dot hybridization to complementary DNA. After 50% Px there was a nearly complete adaptation of proinsulin mRNA. After 90% Px a marked increase of proinsulin mRNA occurred, but it was insufficient and it was not maintained with time. The deficit in insulin production is related to development of hyperglycemia.
Introduction
Diabetes mellitus represents a heterogeneous group of disorders characterized by hyperglycemia, and by varying degrees of apparent insulin insufficiency. Despite an appreciation of the importance of insulin production, there has been no adequate quantitative assessment of capacity to produce insulin in humans. In insulin-dependent diabetes mellitus a deficit in insulin production has been established by the loss of endogenous insulin secretion (1, 2) , and by a paucity of B cells in pancreas at autopsy (3) (4) (5) (6) . In noninsulin-dependent diabetes mellitus the deficit of insulin production is less well characterized. Reductions of B cell number (6, 7) and of extractable pancreatic insulin (8, 9) have been observed at autopsy, although these findings have not been consistent (3) (4) (5) and their functional significance is unknown. Insulin resistance has been shown to be important in increasing the metabolic demands for insulin, but pathogenetic relationships between insulin sensitivity and capacity to produce insulin remain unclear (10) . Estimation of ability to produce insulin has been inferred largely from tests of insulin secretion; ultimately, a lack of ability to secrete insulin in quantities sufficient to meet metabolic demands is evident.
The importance of a quantitative assessment of insulin biosynthesis has led to numerous studies in experimental animals. In isolated pancreatic islets, measurements of isotope incorporation into insulin have revealed ability to modulate insulin biosynthesis with in vitro manipulation (11) (12) (13) (14) , but applicability of these findings to synthesis in vivo is unclear. In rats given streptozotocin as neonates, examination of islets has shown increased [3H]leucine incorporation into insulin (15) , but demonstration of reductions in pancreatic insulin content and in [3Hjleucine incorporation into proinsulin in vivo (16, 17) have limited an interpretation ofthe islet findings.
Measurement of proinsulin messenger RNA (mRNA)' has conveyed potential for estimating in vivo capacity to produce insulin (16, 17) . Modulation of proinsulin mRNA concentration has been shown in studies assessing the physiologic regulation of insulin production (17) (18) (19) (20) (21) (22) . A correlation has been shown in rats between pancreatic proinsulin mRNA concentration and rates of in vivo incorporation of [3Hjleucine into proinsulin, showing comparable ability to assess rates of insulin biosynthesis (16, 17) . A correlation between tissue mRNA levels and protein synthetic rates also has been shown for other protein systems in vitro (23, 24) and in vivo (25, 26) .
These studies were designed to assess the relationship between functional capacity to produce insulin and development of hyperglycemia. Pancreatectomy has been recognized as a model allowing investigation of the correlation between limitation of islet number and expression of diabetes (27) (28) (29) (30) (31) . Morphologic observations in early studies have shown adaptive increases in B cell number (27, 28) , often followed by evidence of islet destruction (28) (29) (30) . More recent study of 90% pancre-atectomy in rats has indicated that abnormalities of glucose tolerance are associated with a loss of glucose-stimulated insulin secretion characteristic of diabetes in man (31) . In the experiments described below, proinsulin mRNA measurement has been used to assess the functional response of insulin production to varying degrees of pancreatectomy, with attention to age and body weight. This assessment has been made in conjunction with glucose tolerance testing, to evaluate further the association of functional capacity to produce insulin and ability to maintain glucose tolerance.
Methods
Pancreatectomy. Male Sprague-Dawley rats, fed ad lib. on Purina Rodent Chow (Ralston Purina Co., St. Louis, MO), were selected for pancreatectomy at 4 wk of age, at -100 g body wt. Litter mates were sorted randomly for sham, 50%, or 90% pancreatectomy. Anesthesia was accomplished using sodium pentobarbital, 3-10 mg/100 g, injected intraperitoneally, followed in most cases by inhalation of diethyl ether. Skin of the ventral abdominal wall was washed with 70% ethanol, and a midline longitudinal incision was made from the sternum to the pubic symphysis. The skin and the muscular anterior abdominal wall were opened separately.
50% pancreatectomy entailed resection of the splenic portion of the pancreas. The spleen was mobilized by breaking mesenteric connections to the stomach, small bowel, and retroperitoneum. Pancreatic tissue was teased from splenic and pancreatic vessels using a cottontipped applicator, resulting in devascularization of -50% of the total pancreatic substance, as determined by weight (data not shown). This portion of the pancreas was removed with sharp dissection -5 mm from the pylorus, leaving a 50% pancreatic remnant.
90% pancreatectomy was performed according to the method of Foglia (30), as recently adopted by Bonner-Weir et al. (31) . The splenic portion was removed as described above, but dissection at the pylorus was extended to leave only a small remnant at the gastroduodenal artery. After mesenteric connections to the colon were broken, the duodenal portion of the pancreas was dissected dorsal and caudal to the common bile duct. Care was taken to preserve duodenal vasculature. The result of this dessection was a 10% remnant, appearing as a crescent of pancreatic tissue lying between the bile duct and the proximal portion of the duodenum.
Sham pancreatectomy was accomplished by gently teasing the entire pancreas with a cotton applicator, after breaking splenic and duodenal mesenteric connections.
After pancreatic manipulation, the muscular abdominal wall was closed with 4-0 silk suture, and the skin was closed with wound clips. Animals were given 1-2 ml of isotonic sodium chloride subcutaneously for volume replacement; no antibiotics were administered. Animals chosen for subsequent studies were drinking and eating ad lib. within 12 h of operation.
Sacrificed animals. Animals were sacrificed in the fed state at 1, 3, and 14 wk after pancreatectomy or sham operation. Before sacrifice, fed blood glucose was measured from tail samples using Dextrostix glucose oxidase reagent strips and an Ames Glucometer (Miles Laboratories Inc., Elkhart, IN). Animals were more heavily anesthestized with sodium pentobarbital, 10-20 mg/100 g body wt. Before respiratory arrest, the abdomen was opened along previous suture lines, and dissection was extended into the thorax. Blood was obtained from the right ventricle for subsequent measurement of serum glucose and insulin.
Intra-abdominal adhesions were broken, and the spleen, pancreas, and duodenum were mobilized. The pancreas or pancreatic remnant was removed by sharp dissection with the spleen, pyloric portion of the stomach, and the duodenal loop en bloc; the common bile duct and accompanying vasculature were cut proximally. Pancreatic tissue was then dissected from the spleen and gut by a combination of blunt and sharp dissection. Accompanying fat and lymphatic tissue were discarded. In the 90% pancreatectomized (Px) animals at 1 and 3 wk after pancreatectomy, the entire 10% pancreatic remnant was homogenized in a guanidine thiocyanate solution for subsequent purification of RNA, as described below. In the 50% Px animals, and in the 90% Px animals after 14 (Fig. 1) .
Glucose tolerance testing. In those rats ultimately sacrificed after 14 wk, intraperitoneal glucose tolerance tests were performed at 3, 6, and 12 wk after operation, using a protocol previously described (31 body weight of the 90% Px animals was lower than that of controls after 3 wk (P < 0.005) and after 14 wk (P < 0.001).
Fed blood glucose was not elevated in the sham-operated animals. There was a minimal difference between the 50% Px animals and the sham-operated controls after 14 wk (50% 132±2 vs. sham 102±4 mg/dl, P < 0.05). The 90% Px animals were not different from controls at 1 wk after pancreatectomy, but showed a higher fed blood glucose after 3 wk (P < 0.05) and a more marked elevation after 14 wk (P < 0.0005). Fig. 3 . An increase in pancreatic weight was shown in all three groups. After 14 wk, the weight of the 50% pancreatic remnant was 50% of control, and the weight of the 10% remnant was 14% of control.
Total pancreatic insulin content increased in the shamoperated animals from I wk to 14 wk after operation (P < 0.001). Insulin content also increased in the 50% Px animals after 3 wk (P < 0.05), but not after 14 wk, at which time pancreatic insulin concentration was reduced (P < 0.05), and total pancreatic insulin was 30% of control. In the 90% Px animals pancreatic insulin was measured only after 14 wk, at which time the total pancreatic insulin content was 15% of control.
Pancreatic RNA andproinsulin mRNA after pancreatectomy. Changes in total pancreatic RNA, proinsulin messenger RNA concentration, and total proinsulin messenger RNA are shown in Table II and Fig. 4 . Changes in total pancreatic RNA resembled those in pancreatic weight. In the control animals an increase in pancreatic RNA was shown from 1 to 14 wk after sham operation (P < 0.005). At 1 wk after pancreatectomy, total RNA was 64% of control in the 50% pancreatic remnant, and 16% of control in the 10% remnant. After 14 wk total RNA was 54% of control in the 50% remnant, and 13% of control in the 10% remnant, reflecting the extent of initial resection.
The concentration of proinsulin messenger RNA, as determined by dot hybridization of total RNA aliquots ( Fig. 1) , increased in the sham-operated animals from 1-14 weeks after operation (P < 0.001). The concentration of proinsulin messenger RNA in the 50% Px animals was not different from control after 1 or 3 wk, but was increased to 165% of control after 14 wk. Contrastingly, in the 90% Px animals, proinsulin mRNA concentration (Fig. 1) was markedly increased at I wk after pancreatectomy, to 220% of control, and after 3 wk, to 250% of control. After 14 wk, however, the concentration of proinsulin messenger RNA was reduced from the 3 wk value (P < 0.01), and was no longer different from control.
The impact of changes in proinsulin mRNA concentration was apparent after calculation of total pancreatic proinsulin mRNA, which is the product of proinsulin mRNA concentration and total pancreatic RNA. Over the 13-wk observation period the sham-operated controls exhibited a more than threefold increase in total proinsulin mRNA (P < 0.001). As proinsulin mRNA concentration in the 50% Px animals was not different from control at 1 or 3 wk after pancreatectomy, total levels of proinsulin mRNA in the 50% remnant were not demonstrably augmented. After 14 wk, however, the increase in proinsulin mRNA concentration observed in the 50% Px animals established a rise in total proinsulin mRNA (P < 0.00 1), such that levels were no longer different from those in shamoperated controls. In the 90% Px animals the marked increases in proinsulin mRNA concentration seen at 1 and 3 wk after Comparison of proinsulin mRNA concentration by anatomic location was accomplished by dividing the pancreas of sham-operated rats into a remnant equivalent head and tail. Data in this analysis were pooled from 3 and 14 wk after operation. The 50% remnant equivalent head was not different from the tail (head, 1.76±0.11 vs. tail, 1.77±0.11 ng/mg RNA, n = 12, NS). The 10% remnant equivalent head showed a lower proinsulin mRNA concentration relative to the corresponding body and tail (head 1.10±0.11 vs. body and tail 1.87±0.11 ng/mg RNA, n = 10, P < 0.001). These differences complement results of previous morphologic observations (38) .
Fasting blood glucose and glucose tolerance after pancreatectomy. The results of intraperitoneal glucose tolerance testing at 3, 6, and 12 wk after pancreatectomy are illustrated in Fig.  5 . These tests were performed in those rats ultimately sacrificed at 14 wk after operation.
Sham-operated control animals (n = 13) showed no change in their glucose profile with time after pancreatectomy. The 50% Px animals (n = 7) demonstrated an impairment of glucose tolerance relative to the sham-operated animals by showing elevated blood glucose at 30 min and at 50 min after 3 and 6 wk (P < 0.01), and at 50 min after 12 wk (P < 0.005).
Comparison of the glucose profiles at 3, 6, and 12 wk revealed no evidence to suggest deterioration of glucose tolerance with time in the 50% Px group. Fasting hyperglycemia was not evident.
The 90% Px animals showed a more marked impairment of glucose tolerance than did the control or the 50% Px Proinsulin Messenger RNA After Pancreatectomy animals at all times tested. At 3 wk (n = 7) and at 6 wk (n = 4) after pancreatectomy this difference was apparent at 30 min and at 50 min after glucose injection (P < 0.01). Worsening of glucose tolerance was apparent in the 90% group after 6 wk, as depicted by the 50-min determination (6 wk 436±59 vs. 3 wk 342±16 mg/dl, P < 0.01). This abnormality of glucose tolerance has been associated with impaired insulin secretion in previous studies (31) . After 12 wk (n = 4), a further deterioration of glucose tolerance was observed, including fasting hyperglycemia (90% 307±101 vs. sham 85±5 mg/dl, P < 0.001), and marked hyperglycemia 10 min after glucose injection (P < 0.001), accompanying the previously observed abnormalities at 30 and 50 min.
Discussion
The proinsulin mRNA measurements presented in these studies represent an important complement to previous observations A relationship between levels of proinsulin mRNA and the physiologic regulation of insulin production has been demonstrated by previous in vivo observations. During fetal pancreatic development there is a specific increase in insulin content relative to total pancreatic protein (39), which is preceded by a comparable increase in proinsulin mRNA (18, 19) . Reduction of proinsulin mRNA has been established as a result of fasting (20) , and ability to increase proinsulin mRNA concentration has been shown in fasted rats after glucose injection (21) . Observations of pancreatic adaptation in rats after removal of insulinoma tissue has correlated increases in proinsulin mRNA with regranulation of atrophic B cells in the presence of hyperglycemia (22) . An abundant proinsulin mRNA content has been observed in genetically obese and hyperglycemic db/ db mice (Orland, M. J., R. Chyn, and M. A. Permutt, manuscript in preparation), associated with hyperinsulinemia and B cell hyperplasia observed in these animals (40) .
The utility of proinsulin mRNA as a quantitative parameter of insulin production has been supported by studies favorably relating proinsulin mRNA to [3H]leucine incorporation into proinsulin in vivo. Parallel measurement of these two parameters in 100 g male Sprague-Dawley rats has shown tight correlation in estimating a twofold reduction of insulin biosynthesis imposed by neonatal streptozotocin treatment (16, 17) , and in assessing a twofold augmentation of insulin biosynthesis apparent in normal and streptozotocin-treated rats given pharmacologic doses of dexamethasone for 4 d (17) . Contrary to the results of short-term labeling studies in isolated pancreatic islets (I1), the in vivo data did not show an important independent contribution of translational activity to insulin biosynthesis under the conditions specified.
The sham-operated rats in this study demonstrated (a) maintenance of fed blood glucose and intraperitoneal glucose tolerance after surgery, and (b) an increase both in proinsulin mRNA concentration and in total proinsulin mRNA content with time. The measurements of total proinsulin mRNA corroborate observations of B cell number and of insulin content with age in normal animals previously reported (41, 42) . Increases in proinsulin mRNA concentration indicate that the regulation of total proinsulin mRNA is not merely a phenomenon reflecting pancreatic growth. The fed blood glucose and intraperitoneal glucose tolerance data suggest that this increase is appropriate to maintain glucose tolerance with time. Increases in total proinsulin mRNA were proportional to changes in body weight; within the study period a ratio of total proinsulin mRNA to body weight, as depicted in Fig. 6 , did not show significant variation.
Observation of the 50% Px animals disclosed (a) euglycemia, initially despite a 50% reduction in proinsulin mRNA relative to controls, (b) mild impairment of glucose tolerance, which did not deteriorate, and (c) ability to regain normal total proinsulin mRNA content with time. It was anticipated that 50% pancreatectomy would not result in diabetes. Functional adaptation was indeed suggested by maintenance of fed and fasting blood glucose comparable to that of the sham-operated controls. Ability to maintain euglycemia despite a 50% reduc- Fig. 6 . Accounting for the reduced proinsulin mRNA concentration evident in the 10% remnant equivalent head, 90% pancreatectomy imposed demand for a greater than 10-fold increase in insulin production to achieve complete adaptation. An adaptation of this magnitude might have been anticipated on the basis of data from isolated rat islets, where significant short-term increases in insulin biosynthesis have been demonstrated (11) (12) (13) (14) . A maximum 3.5-fold increase in proinsulin mRNA concentration was observed in this study at 3 wk after pancreatectomy, associated with a rise of proinsulin mRNA/ body weight to 40% of control. Although the absolute levels of insulin production remain unknown, serum insulin was reduced, fed hyperglycemia became evident, and intraperitoneal glucose tolerance was impaired more dramatically than after 50% pancreatectomy, attesting to an insufficiency of the adaptive response. Inability to maintain adaptive increases in insulin production was suggested after 6 wk by the worsening of intraperitoneal glucose tolerance, and after 12 wk by the appearance of fasting hyperglycemia and glycosuria. After 14 wk the reduction of proinsulin mRNA was associated with marked hypoinsulinemia.
The factors determining appropriate levels of proinsulin mRNA and rates of insulin biosynthesis are unknown, and mechanisms by which a loss of adaptive proinsulin mRNA response occurred with time in the 90% Px animals are not apparent. Hyperglycemia was not evident as a promoter of the increases in proinsulin mRNA observed among sham-operated or 50% Px animals, although changes in glucose levels within a physiologic range may be significant for proinsulin mRNA regulation. The association of elevated proinsulin mRNA with reduced pancreatic insulin content after 14 wk is interesting in this regard, and suggests a relationship between the depletion of B cell insulin stores and the stimulation of insulin biosynthesis. Prolonged hyperglycemia may be responsible for the deterioration of proinsulin mRNA and of insulin biosynthetic capacity in the 90% Px group, supporting previous observations of B cell degeneration (29, 44) . On the other hand, it is possible that further observation may reveal a loss of proinsulin mRNA response in 90% Px animals, or even in 50% Px animals, not related to antecedent hyperglycemic stresses (45) .
The results of these experiments are directly applicable to pancreatic diabetes in man, including that related to exocrine pancreatic diseases or to surgery. Pancreatectomy has certainly been related to the development of diabetes in humans, but the degree of pancreatectomy necessary for subsequent development of diabetes has been unclear, both because of an imprecise documentation of the extent of pancreatic resections, and because of the coexistence of pancreatic disease in patients undergoing surgery (46, 47) . Hemipancreatectomy is now being performed in normal individuals who are donating tissue to diabetic relatives (48) . Observation of these donors has disclosed mild impairment of oral and intravenous glucose tolerance, which seems to improve within I yr after operation, but which might be worsened with obesity (49) . In an analogous fashion, limitation of the adaptive responses seen in these studies may be important toward anticipating the behavior of islet allografts, and in a consideration of the critical mass of islet tissue necessary to maintain adequate insulin production in transplant recipients.
These observations of functional adaptation also may be applicable to an understanding of primary diabetes in man. Although immune destruction of B cells seems to account for the development of insulin insufficiency in insulin-dependent diabetes, many patients show a remission from hyperglycemia early in their clinical course. This remission may represent an adaptive response of remaining B cells, which in most afflicted individuals is not maintained. The relative contributions of deficient insulin production and of insulin resistance are uncertain in the pathogenesis of noninsulin-dependent diabetes (10) , but an ultimate finding is a lack of insulin necessary to meet metabolic demands. A primary abnormality of insulin resistance, such as that imposed by obesity or by pregnancy, may augment insulin production in a manner similar to pancreatectomy. Tendency to diabetes may be related to an inability to adapt fully to augmented demands, or to an inability to maintain a functional adaptation with time, heralded by a worsening of glucose tolerance similar to that seen in 90% Px rats. Testing of these hypotheses requires further understanding of the spectrum of insulin biosynthetic capacity in man, and may be accomplished when tests that describe insulin production in man are elucidated.
